Frank Takkinen
Stock Analyst at Lake Street
(1.72)
# 3,452
Out of 4,974 analysts
688
Total ratings
39.6%
Success rate
n/a
Average return
Main Sectors:
Stocks Rated by Frank Takkinen
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| AXGN Axogen | Reiterated: Buy | $55 | $44.96 | +22.33% | 15 | Sep 14, 2026 | |
| MDXG MiMedx Group | Reiterated: Buy | $7 | $4.72 | +48.31% | 10 | Sep 8, 2026 | |
| CLPT ClearPoint Neuro | Reiterated: Buy | $25 | $13.15 | +90.11% | 51 | Sep 3, 2026 | |
| TELA TELA Bio | Reiterated: Buy | $2 | $1.09 | +83.49% | 41 | Sep 3, 2026 | |
| XAIR Beyond Air | Initiated Coverage: Buy | $10 | $3.13 | +219.49% | 1 | Sep 1, 2026 | |
| RCEL AVITA Medical | Reiterated: Buy | $8 → $12 | $10.21 | +17.53% | 14 | Aug 28, 2026 | |
| SMTI Sanara MedTech | Reiterated: Hold | $35 | $35.11 | -0.31% | 4 | Aug 26, 2026 | |
| LNSR LENSAR | Reiterated: Buy | $13 | $7.60 | +71.17% | 19 | Aug 25, 2026 | |
| SGHT Sight Sciences | Reiterated: Buy | $12 | $8.11 | +47.97% | 28 | Aug 19, 2026 | |
| ELUT Elutia | Reiterated: Buy | $5 | $0.80 | +525.00% | 33 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.77 | +419.48% | 16 | Aug 18, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $21 → $15 | $11.25 | +33.33% | 2 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $3 | $1.32 | +127.27% | 39 | Aug 12, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $25.38 | +77.30% | 37 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $14 → $3.5 | $3.00 | +16.67% | 47 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $0.8012 | +212.03% | 20 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $4.78 | +67.36% | 22 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $50 | $16.28 | +207.13% | 5 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $8 | $3.16 | +153.16% | 35 | Aug 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $120 | $82.41 | +45.61% | 20 | Aug 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $19.23 | +4.00% | 13 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $1.91 | +109.42% | 18 | Jul 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 | $14.25 | +40.35% | 49 | Jul 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $24 | $15.68 | +53.06% | 5 | Jul 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $23 | $11.15 | +106.28% | 5 | May 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $0.4621 | +765.61% | 7 | May 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 → $135 | $80.24 | +68.25% | 12 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $20 → $15 | $8.34 | +79.86% | 9 | Jan 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $6 | $0.71 | +745.07% | 17 | Oct 7, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $74.60 | n/a | 28 | Aug 27, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $2.5 | $2.96 | n/a | 18 | Aug 9, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $10 | $4.08 | n/a | 11 | Jul 22, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 | $3.92 | n/a | 6 | May 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $22.14 → $19.37 | $7.92 | n/a | 9 | Nov 3, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 → $40 | $0.000001 | n/a | 4 | May 31, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $4 → $12 | $0.0955 | n/a | 3 | Feb 14, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1 | $2.73 | n/a | 4 | Sep 29, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $14 → $10 | $3.46 | n/a | 7 | May 11, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $5.55 | $0.27 | n/a | 1 | Apr 5, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | $6 → $10 | $0.0003 | n/a | 3 | Mar 31, 2022 |
Axogen
Sep 14, 2026
Reiterated: Buy
Price Target: $55
Current: $44.96
Upside: +22.33%
MiMedx Group
Sep 8, 2026
Reiterated: Buy
Price Target: $7
Current: $4.72
Upside: +48.31%
ClearPoint Neuro
Sep 3, 2026
Reiterated: Buy
Price Target: $25
Current: $13.15
Upside: +90.11%
TELA Bio
Sep 3, 2026
Reiterated: Buy
Price Target: $2
Current: $1.09
Upside: +83.49%
Beyond Air
Sep 1, 2026
Initiated Coverage: Buy
Price Target: $10
Current: $3.13
Upside: +219.49%
AVITA Medical
Aug 28, 2026
Reiterated: Buy
Price Target: $8 → $12
Current: $10.21
Upside: +17.53%
Sanara MedTech
Aug 26, 2026
Reiterated: Hold
Price Target: $35
Current: $35.11
Upside: -0.31%
LENSAR
Aug 25, 2026
Reiterated: Buy
Price Target: $13
Current: $7.60
Upside: +71.17%
Sight Sciences
Aug 19, 2026
Reiterated: Buy
Price Target: $12
Current: $8.11
Upside: +47.97%
Elutia
Aug 18, 2026
Reiterated: Buy
Price Target: $5
Current: $0.80
Upside: +525.00%
Aug 18, 2026
Reiterated: Buy
Price Target: $4
Current: $0.77
Upside: +419.48%
Aug 14, 2026
Rated: Buy
Price Target: $21 → $15
Current: $11.25
Upside: +33.33%
Aug 12, 2026
Reiterated: Buy
Price Target: $4 → $3
Current: $1.32
Upside: +127.27%
Aug 7, 2026
Reiterated: Buy
Price Target: $45
Current: $25.38
Upside: +77.30%
Aug 7, 2026
Downgraded: Hold
Price Target: $14 → $3.5
Current: $3.00
Upside: +16.67%
Aug 7, 2026
Reiterated: Buy
Price Target: $2.5
Current: $0.8012
Upside: +212.03%
Aug 7, 2026
Reiterated: Buy
Price Target: $8
Current: $4.78
Upside: +67.36%
Aug 7, 2026
Reiterated: Buy
Price Target: $50
Current: $16.28
Upside: +207.13%
Aug 6, 2026
Reiterated: Buy
Price Target: $8
Current: $3.16
Upside: +153.16%
Aug 3, 2026
Reiterated: Buy
Price Target: $120
Current: $82.41
Upside: +45.61%
Jul 30, 2026
Reiterated: Buy
Price Target: $20
Current: $19.23
Upside: +4.00%
Jul 30, 2026
Reiterated: Buy
Price Target: $4
Current: $1.91
Upside: +109.42%
Jul 29, 2026
Reiterated: Buy
Price Target: $20
Current: $14.25
Upside: +40.35%
Jul 14, 2026
Reiterated: Buy
Price Target: $24
Current: $15.68
Upside: +53.06%
May 26, 2026
Reiterated: Buy
Price Target: $23
Current: $11.15
Upside: +106.28%
May 21, 2026
Reiterated: Buy
Price Target: $4
Current: $0.4621
Upside: +765.61%
May 6, 2026
Reiterated: Buy
Price Target: $110 → $135
Current: $80.24
Upside: +68.25%
Jan 23, 2026
Reiterated: Buy
Price Target: $20 → $15
Current: $8.34
Upside: +79.86%
Oct 7, 2025
Reiterated: Buy
Price Target: $6
Current: $0.71
Upside: +745.07%
Aug 27, 2025
Reiterated: Buy
Price Target: $150
Current: $74.60
Upside: n/a
Aug 9, 2024
Reiterated: Buy
Price Target: $2.5
Current: $2.96
Upside: n/a
Jul 22, 2024
Reiterated: Buy
Price Target: $10
Current: $4.08
Upside: n/a
May 15, 2024
Reiterated: Buy
Price Target: $4
Current: $3.92
Upside: n/a
Nov 3, 2023
Reiterated: Buy
Price Target: $22.14 → $19.37
Current: $7.92
Upside: n/a
May 31, 2023
Reiterated: Buy
Price Target: $150 → $40
Current: $0.000001
Upside: n/a
Feb 14, 2023
Reiterated: Buy
Price Target: $4 → $12
Current: $0.0955
Upside: n/a
Sep 29, 2022
Reiterated: Buy
Price Target: $1
Current: $2.73
Upside: n/a
May 11, 2022
Reiterated: Buy
Price Target: $14 → $10
Current: $3.46
Upside: n/a
Apr 5, 2022
Initiated Coverage: Buy
Price Target: $5.55
Current: $0.27
Upside: n/a
Mar 31, 2022
Downgraded: Hold
Price Target: $6 → $10
Current: $0.0003
Upside: n/a